Compare Herbalife Nutrition Ltd (HLF) vs Tempus AI (TEM) Price & Performance

Herbalife (HLF) trades at $12.65, up 0.56% with a bullish technical signal supported by moving averages. The company shows solid fundamentals with a low P/E of 8.11 and P/S of 0.26, though recent earnings have been mixed with two misses and one beat. A $250 million share repurchase program and CEO transition in October 2026 highlight ongoing corporate developments. Cash flow trends show improvement with projected positive net cash flow of $50 million in 2026.

HLF presents a value opportunity with discounted valuation metrics and analyst consensus target of $19.00 (50% upside). However, risks include negative shareholder equity, high debt levels, and inconsistent earnings performance. The stock offers potential for investors comfortable with turnaround execution risks in the wellness sector.

Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.

The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.